BioSpace News Archive

Werewolf Therapeutics, Inc. announced upcoming oncology research and investor community events in which Werewolf scientists and management will participate.

Verrica Pharmaceuticals Inc. (Verrica) (Nasdaq: VRCA), a dermatology therapeutics company developing medications for skin diseases requiring medical interventions, today announced financial results for the third quarter ended September 30, 2022.

TFF Pharmaceuticals, Inc. announced that it will release its financial results and business update for the third quarter of 2022 on Monday, November 14, 2022, at the close of the U.S. financial markets.

Apellis Pharmaceuticals, Inc. (Nasdaq: APLS), a global biopharmaceutical company and leader in complement, today announced its third quarter 2022 financial results and business highlights.

Ocuphire Pharma, Inc. announced it has concluded an exclusive license agreement with FamyGen Life Sciences, Inc. for the development and commercialization of Nyxol across three indications in US, Europe, Japan, India, China and other global markets.

Roivant Sciences Ltd., a next-generation biopharmaceutical company dedicated to improving the delivery of healthcare to patients, announced the commencement of a proposed underwritten public offering of $150,000,000 of common shares.

Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) today announced that it will host an investor conference call on Monday, November 14, 2022 at 2:00 p.m. PT to discuss its financial and operating results for the third quarter 2022 as well as provide a corporate update.

Impel Pharmaceuticals Inc. (NASDAQ: IMPL), a commercial-stage pharmaceutical company developing transformative therapies for people suffering from diseases with high unmet medical needs, today announced it will host a live webcast on Monday, November 14, 2022, at 8:30 a.m. ET to report its third quarter 2022 financial results and provide a business update.

Experts from NYU Langone Health presented their latest clinical findings and research discoveries at the American Heart Association’s Scientific Sessions 2022, from Nov. 4 to Nov. 7, in Chicago.

Curis, Inc. announced that the Company along with its collaborative partners will be presenting three posters at the upcoming 37th Annual Meeting of the Society for Immunotherapy of Cancer being held in Boston, MA and virtually from November 8th to November 12th.